Table 2 Week 48 results (ITT-E, Missing = excluded).
| Â | ARV experienced | ARV experienced | ARV experienced | ARV naive | ARV naive | ARV naive |
|---|---|---|---|---|---|---|
| Â | Truvada (n = 60) | Kivexa (n = 53) | p-value | Truvada (n = 64) | Kivexa (n = 50) | p-value |
Viral load <50 copies/ml | 47/49 (95.9%) | 35/36 (97.2%) | 1.00 | 56/59 (94.9%) | 29/33 (87.9%) | 0.22 |
Median CD4 increase (cells/mm3) | 83 | 62 | 0.36 | 208 | 170 | 0.59 |
Withdrawn due to adverse events | 1 | 0 | Â | 0 | 0 | Â |
Suspected ABC HSR | 0 | 0 | Â | 0 | 1 | Â |
Proximal renal tubular dysfunction | 0 | 0 | Â | 0 | 0 | Â |
Virological failure | 0 | 1 | Â | 0 | 2 | Â |